Structure

Physi-Chem Properties

Molecular Weight:  286.12
Volume:  296.261
LogP:  3.824
LogD:  3.411
LogS:  -3.329
# Rotatable Bonds:  2
TPSA:  58.92
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.887
Synthetic Accessibility Score:  2.899
Fsp3:  0.294
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.671
MDCK Permeability:  1.5121404430828989e-05
Pgp-inhibitor:  0.004
Pgp-substrate:  0.039
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.003

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.061
Plasma Protein Binding (PPB):  97.02922821044922%
Volume Distribution (VD):  1.16
Pgp-substrate:  2.4243130683898926%

ADMET: Metabolism

CYP1A2-inhibitor:  0.791
CYP1A2-substrate:  0.954
CYP2C19-inhibitor:  0.845
CYP2C19-substrate:  0.537
CYP2C9-inhibitor:  0.727
CYP2C9-substrate:  0.953
CYP2D6-inhibitor:  0.601
CYP2D6-substrate:  0.915
CYP3A4-inhibitor:  0.347
CYP3A4-substrate:  0.587

ADMET: Excretion

Clearance (CL):  14.103
Half-life (T1/2):  0.542

ADMET: Toxicity

hERG Blockers:  0.082
Human Hepatotoxicity (H-HT):  0.168
Drug-inuced Liver Injury (DILI):  0.098
AMES Toxicity:  0.038
Rat Oral Acute Toxicity:  0.408
Maximum Recommended Daily Dose:  0.692
Skin Sensitization:  0.934
Carcinogencity:  0.292
Eye Corrosion:  0.004
Eye Irritation:  0.884
Respiratory Toxicity:  0.728

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC17809

Natural Product ID:  NPC17809
Common Name*:   (2S)-4',5-Dihydroxy-7-Methoxy-8-Methylflavan
IUPAC Name:   (2S)-2-(4-hydroxyphenyl)-7-methoxy-8-methyl-3,4-dihydro-2H-chromen-5-ol
Synonyms:  
Standard InCHIKey:  FAZHAXUNXPANOK-HNNXBMFYSA-N
Standard InCHI:  InChI=1S/C17H18O4/c1-10-16(20-2)9-14(19)13-7-8-15(21-17(10)13)11-3-5-12(18)6-4-11/h3-6,9,15,18-19H,7-8H2,1-2H3/t15-/m0/s1
SMILES:  Cc1c(cc(c2CC[C@@H](c3ccc(cc3)O)Oc12)O)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL253562
PubChem CID:   44257197
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0002585] O-methylated flavonoids
          • [CHEMONTID:0002592] 7-O-methylated flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO12714 Dracaena cochinchinensis Species Asparagaceae Eukaryota n.a. n.a. n.a. PMID[12016928]
NPO12714 Dracaena cochinchinensis Species Asparagaceae Eukaryota stems Ningming County, Guangxi autonomous region, China 2006-Jan PMID[17883259]
NPO12714 Dracaena cochinchinensis Species Asparagaceae Eukaryota n.a. n.a. n.a. PMID[21661731]
NPO12714 Dracaena cochinchinensis Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO12714 Dracaena cochinchinensis Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO12714 Dracaena cochinchinensis Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO12714 Dracaena cochinchinensis Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT451 Organism Helicobacter pylori Helicobacter pylori MIC = 55900.0 nM PMID[549922]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC17809 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC103420
1.0 High Similarity NPC188022
1.0 High Similarity NPC102540
1.0 High Similarity NPC285040
0.9916 High Similarity NPC276212
0.9915 High Similarity NPC106914
0.9915 High Similarity NPC246648
0.9915 High Similarity NPC197351
0.9915 High Similarity NPC134195
0.9915 High Similarity NPC86502
0.9831 High Similarity NPC38761
0.9831 High Similarity NPC76465
0.9752 High Similarity NPC274717
0.9746 High Similarity NPC100099
0.9746 High Similarity NPC36016
0.9669 High Similarity NPC149796
0.959 High Similarity NPC38664
0.959 High Similarity NPC53986
0.9516 High Similarity NPC206224
0.9516 High Similarity NPC300875
0.9516 High Similarity NPC12875
0.9516 High Similarity NPC280653
0.9516 High Similarity NPC236014
0.9516 High Similarity NPC103799
0.9516 High Similarity NPC129106
0.9516 High Similarity NPC164574
0.9516 High Similarity NPC118114
0.9516 High Similarity NPC228369
0.9516 High Similarity NPC268917
0.9516 High Similarity NPC129784
0.9516 High Similarity NPC196765
0.9516 High Similarity NPC476166
0.9516 High Similarity NPC207892
0.9516 High Similarity NPC17343
0.9516 High Similarity NPC150011
0.9512 High Similarity NPC93962
0.9496 High Similarity NPC54972
0.9492 High Similarity NPC93398
0.9492 High Similarity NPC258979
0.9492 High Similarity NPC8283
0.944 High Similarity NPC13005
0.9435 High Similarity NPC27187
0.9435 High Similarity NPC470225
0.9431 High Similarity NPC222572
0.9431 High Similarity NPC87224
0.9426 High Similarity NPC283049
0.9426 High Similarity NPC26879
0.9426 High Similarity NPC230479
0.9426 High Similarity NPC50315
0.9407 High Similarity NPC59561
0.9407 High Similarity NPC172253
0.9365 High Similarity NPC85435
0.936 High Similarity NPC181497
0.936 High Similarity NPC211413
0.936 High Similarity NPC271945
0.936 High Similarity NPC68205
0.936 High Similarity NPC244888
0.936 High Similarity NPC293203
0.936 High Similarity NPC118683
0.936 High Similarity NPC164804
0.9355 High Similarity NPC134360
0.9322 High Similarity NPC131118
0.9291 High Similarity NPC97834
0.9291 High Similarity NPC296915
0.9291 High Similarity NPC124085
0.9291 High Similarity NPC223008
0.9291 High Similarity NPC473107
0.9291 High Similarity NPC117048
0.9291 High Similarity NPC225696
0.9291 High Similarity NPC115335
0.9291 High Similarity NPC198154
0.9274 High Similarity NPC47283
0.9274 High Similarity NPC39064
0.9262 High Similarity NPC159132
0.9244 High Similarity NPC295259
0.9219 High Similarity NPC473413
0.9213 High Similarity NPC92805
0.9213 High Similarity NPC77196
0.9206 High Similarity NPC162801
0.9187 High Similarity NPC207179
0.9187 High Similarity NPC278552
0.9187 High Similarity NPC167571
0.9174 High Similarity NPC193364
0.9174 High Similarity NPC476633
0.916 High Similarity NPC74821
0.9153 High Similarity NPC54507
0.9153 High Similarity NPC229147
0.9153 High Similarity NPC85292
0.9147 High Similarity NPC20829
0.9147 High Similarity NPC3049
0.9147 High Similarity NPC471522
0.9147 High Similarity NPC18189
0.9147 High Similarity NPC262585
0.9113 High Similarity NPC262573
0.9113 High Similarity NPC471215
0.9077 High Similarity NPC470308
0.9077 High Similarity NPC474687
0.9077 High Similarity NPC470307
0.9068 High Similarity NPC464
0.9068 High Similarity NPC185541
0.9062 High Similarity NPC11060
0.9062 High Similarity NPC215037
0.9016 High Similarity NPC190454
0.9016 High Similarity NPC97432
0.9008 High Similarity NPC32630
0.9008 High Similarity NPC475836
0.9 High Similarity NPC470802
0.8992 High Similarity NPC476617
0.8992 High Similarity NPC476615
0.8992 High Similarity NPC476616
0.8976 High Similarity NPC32463
0.8952 High Similarity NPC294156
0.8952 High Similarity NPC256015
0.8943 High Similarity NPC150026
0.8923 High Similarity NPC112246
0.8923 High Similarity NPC94750
0.8923 High Similarity NPC125579
0.8923 High Similarity NPC470356
0.8923 High Similarity NPC474206
0.8923 High Similarity NPC112939
0.8923 High Similarity NPC151224
0.8923 High Similarity NPC121812
0.8923 High Similarity NPC61946
0.888 High Similarity NPC81641
0.8872 High Similarity NPC5155
0.8872 High Similarity NPC265075
0.8871 High Similarity NPC474160
0.8864 High Similarity NPC260741
0.8864 High Similarity NPC70682
0.8855 High Similarity NPC16435
0.8855 High Similarity NPC227503
0.8855 High Similarity NPC474639
0.8855 High Similarity NPC230734
0.8855 High Similarity NPC306441
0.8855 High Similarity NPC234952
0.8846 High Similarity NPC317380
0.8846 High Similarity NPC131950
0.8806 High Similarity NPC5253
0.8806 High Similarity NPC49542
0.8806 High Similarity NPC139976
0.8806 High Similarity NPC230718
0.8806 High Similarity NPC84207
0.8806 High Similarity NPC128337
0.88 High Similarity NPC270030
0.879 High Similarity NPC57199
0.8788 High Similarity NPC107551
0.8788 High Similarity NPC102904
0.8788 High Similarity NPC176051
0.8788 High Similarity NPC326797
0.8788 High Similarity NPC211549
0.8788 High Similarity NPC103976
0.8788 High Similarity NPC87777
0.8788 High Similarity NPC262328
0.8788 High Similarity NPC474282
0.8779 High Similarity NPC164787
0.8779 High Similarity NPC195022
0.8779 High Similarity NPC260898
0.8779 High Similarity NPC234333
0.8779 High Similarity NPC47398
0.8769 High Similarity NPC177712
0.8769 High Similarity NPC24913
0.8769 High Similarity NPC475840
0.8769 High Similarity NPC263064
0.876 High Similarity NPC33270
0.876 High Similarity NPC160623
0.876 High Similarity NPC474933
0.876 High Similarity NPC69261
0.875 High Similarity NPC16577
0.874 High Similarity NPC473134
0.874 High Similarity NPC46978
0.8731 High Similarity NPC277331
0.8731 High Similarity NPC35216
0.8731 High Similarity NPC100482
0.873 High Similarity NPC293801
0.873 High Similarity NPC105031
0.873 High Similarity NPC113495
0.8722 High Similarity NPC144512
0.8722 High Similarity NPC471388
0.8722 High Similarity NPC137262
0.8722 High Similarity NPC47040
0.8722 High Similarity NPC35501
0.8722 High Similarity NPC278600
0.8722 High Similarity NPC37428
0.8712 High Similarity NPC173660
0.8712 High Similarity NPC265433
0.8712 High Similarity NPC269091
0.8712 High Similarity NPC248727
0.8712 High Similarity NPC162659
0.8712 High Similarity NPC302701
0.8712 High Similarity NPC270456
0.8692 High Similarity NPC202762
0.8692 High Similarity NPC185604
0.8692 High Similarity NPC78770
0.8692 High Similarity NPC86655
0.8692 High Similarity NPC261619
0.8692 High Similarity NPC126029
0.8692 High Similarity NPC61477
0.8692 High Similarity NPC219876
0.8692 High Similarity NPC472798
0.8692 High Similarity NPC127624

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC17809 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9435 High Similarity NPD4907 Clinical (unspecified phase)
0.9274 High Similarity NPD4908 Phase 1
0.9174 High Similarity NPD1610 Phase 2
0.916 High Similarity NPD1548 Phase 1
0.875 High Similarity NPD4625 Phase 3
0.8692 High Similarity NPD1612 Clinical (unspecified phase)
0.8692 High Similarity NPD1613 Approved
0.8527 High Similarity NPD1529 Clinical (unspecified phase)
0.8485 Intermediate Similarity NPD5124 Phase 1
0.8485 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.845 Intermediate Similarity NPD2861 Phase 2
0.845 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8425 Intermediate Similarity NPD4749 Approved
0.8397 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8397 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.8345 Intermediate Similarity NPD7213 Phase 3
0.8345 Intermediate Similarity NPD7212 Phase 2
0.8321 Intermediate Similarity NPD3027 Phase 3
0.8309 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8309 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8268 Intermediate Similarity NPD422 Phase 1
0.8248 Intermediate Similarity NPD1549 Phase 2
0.8156 Intermediate Similarity NPD7447 Phase 1
0.8156 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8082 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8069 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.8058 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.8027 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7984 Intermediate Similarity NPD1091 Approved
0.7966 Intermediate Similarity NPD940 Approved
0.7966 Intermediate Similarity NPD846 Approved
0.7956 Intermediate Similarity NPD4538 Approved
0.7956 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7956 Intermediate Similarity NPD4536 Approved
0.7945 Intermediate Similarity NPD7411 Suspended
0.7939 Intermediate Similarity NPD8651 Approved
0.7919 Intermediate Similarity NPD7075 Discontinued
0.7902 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7877 Intermediate Similarity NPD4380 Phase 2
0.7869 Intermediate Similarity NPD2684 Approved
0.7868 Intermediate Similarity NPD4060 Phase 1
0.7863 Intermediate Similarity NPD6583 Phase 3
0.7863 Intermediate Similarity NPD6582 Phase 2
0.7863 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD6671 Approved
0.7851 Intermediate Similarity NPD968 Approved
0.7842 Intermediate Similarity NPD2796 Approved
0.7838 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.782 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7801 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7801 Intermediate Similarity NPD1652 Phase 2
0.7787 Intermediate Similarity NPD290 Approved
0.777 Intermediate Similarity NPD1934 Approved
0.777 Intermediate Similarity NPD7033 Discontinued
0.777 Intermediate Similarity NPD5588 Approved
0.777 Intermediate Similarity NPD1510 Phase 2
0.777 Intermediate Similarity NPD5960 Phase 3
0.776 Intermediate Similarity NPD5535 Approved
0.776 Intermediate Similarity NPD7843 Approved
0.7746 Intermediate Similarity NPD3750 Approved
0.7737 Intermediate Similarity NPD1240 Approved
0.7733 Intermediate Similarity NPD7768 Phase 2
0.7721 Intermediate Similarity NPD6798 Discontinued
0.7718 Intermediate Similarity NPD7819 Suspended
0.7714 Intermediate Similarity NPD6099 Approved
0.7714 Intermediate Similarity NPD6100 Approved
0.7687 Intermediate Similarity NPD6584 Phase 3
0.7651 Intermediate Similarity NPD6801 Discontinued
0.7639 Intermediate Similarity NPD5058 Phase 3
0.763 Intermediate Similarity NPD3018 Phase 2
0.7626 Intermediate Similarity NPD1607 Approved
0.7622 Intermediate Similarity NPD7466 Approved
0.7622 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7612 Intermediate Similarity NPD2797 Approved
0.7578 Intermediate Similarity NPD7157 Approved
0.7566 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7557 Intermediate Similarity NPD5846 Approved
0.7557 Intermediate Similarity NPD6516 Phase 2
0.7556 Intermediate Similarity NPD3691 Phase 2
0.7556 Intermediate Similarity NPD3690 Phase 2
0.7542 Intermediate Similarity NPD2860 Approved
0.7542 Intermediate Similarity NPD2859 Approved
0.7537 Intermediate Similarity NPD3225 Approved
0.7532 Intermediate Similarity NPD6959 Discontinued
0.752 Intermediate Similarity NPD5451 Approved
0.7518 Intermediate Similarity NPD3846 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3892 Phase 2
0.7483 Intermediate Similarity NPD2424 Discontinued
0.748 Intermediate Similarity NPD821 Approved
0.7468 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7466 Intermediate Similarity NPD6799 Approved
0.7465 Intermediate Similarity NPD1551 Phase 2
0.7464 Intermediate Similarity NPD3268 Approved
0.7463 Intermediate Similarity NPD2982 Phase 2
0.7463 Intermediate Similarity NPD2983 Phase 2
0.7458 Intermediate Similarity NPD2934 Approved
0.7458 Intermediate Similarity NPD2933 Approved
0.745 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7447 Intermediate Similarity NPD7097 Phase 1
0.7447 Intermediate Similarity NPD2200 Suspended
0.7442 Intermediate Similarity NPD2557 Approved
0.7438 Intermediate Similarity NPD1242 Phase 1
0.7429 Intermediate Similarity NPD6355 Discontinued
0.7415 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD6233 Phase 2
0.7407 Intermediate Similarity NPD6696 Suspended
0.7405 Intermediate Similarity NPD6581 Approved
0.7405 Intermediate Similarity NPD6580 Approved
0.7397 Intermediate Similarity NPD6667 Approved
0.7397 Intermediate Similarity NPD6666 Approved
0.7394 Intermediate Similarity NPD3748 Approved
0.7389 Intermediate Similarity NPD6166 Phase 2
0.7389 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7388 Intermediate Similarity NPD2981 Phase 2
0.7385 Intermediate Similarity NPD3596 Phase 2
0.7383 Intermediate Similarity NPD1653 Approved
0.7381 Intermediate Similarity NPD4750 Phase 3
0.7379 Intermediate Similarity NPD4535 Phase 3
0.7376 Intermediate Similarity NPD3052 Approved
0.7376 Intermediate Similarity NPD3054 Approved
0.7368 Intermediate Similarity NPD2801 Approved
0.7358 Intermediate Similarity NPD5844 Phase 1
0.7355 Intermediate Similarity NPD3020 Approved
0.7351 Intermediate Similarity NPD6072 Discontinued
0.7348 Intermediate Similarity NPD6830 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD1511 Approved
0.7347 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD7041 Phase 2
0.7343 Intermediate Similarity NPD2935 Discontinued
0.7333 Intermediate Similarity NPD5327 Phase 3
0.7333 Intermediate Similarity NPD3685 Discontinued
0.7329 Intermediate Similarity NPD6559 Discontinued
0.7324 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7319 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD5403 Approved
0.731 Intermediate Similarity NPD6674 Discontinued
0.7305 Intermediate Similarity NPD5735 Approved
0.7305 Intermediate Similarity NPD4340 Discontinued
0.7293 Intermediate Similarity NPD4626 Approved
0.7292 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD6005 Phase 3
0.7292 Intermediate Similarity NPD6004 Phase 3
0.7292 Intermediate Similarity NPD6002 Phase 3
0.7287 Intermediate Similarity NPD5283 Phase 1
0.7286 Intermediate Similarity NPD6407 Approved
0.7286 Intermediate Similarity NPD6405 Approved
0.7285 Intermediate Similarity NPD6599 Discontinued
0.7273 Intermediate Similarity NPD1894 Discontinued
0.7273 Intermediate Similarity NPD3882 Suspended
0.7261 Intermediate Similarity NPD7229 Phase 3
0.726 Intermediate Similarity NPD4628 Phase 3
0.7255 Intermediate Similarity NPD8455 Phase 2
0.7254 Intermediate Similarity NPD4097 Suspended
0.7248 Intermediate Similarity NPD1512 Approved
0.7244 Intermediate Similarity NPD5494 Approved
0.7239 Intermediate Similarity NPD3496 Discontinued
0.7239 Intermediate Similarity NPD3847 Discontinued
0.7234 Intermediate Similarity NPD5837 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD2238 Phase 2
0.7234 Intermediate Similarity NPD4140 Approved
0.7222 Intermediate Similarity NPD4477 Approved
0.7222 Intermediate Similarity NPD4476 Approved
0.7218 Intermediate Similarity NPD3443 Approved
0.7218 Intermediate Similarity NPD3444 Approved
0.7218 Intermediate Similarity NPD3049 Approved
0.7218 Intermediate Similarity NPD3445 Approved
0.7218 Intermediate Similarity NPD5691 Approved
0.7214 Intermediate Similarity NPD1296 Phase 2
0.7205 Intermediate Similarity NPD7074 Phase 3
0.7192 Intermediate Similarity NPD2800 Approved
0.719 Intermediate Similarity NPD37 Approved
0.7185 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7185 Intermediate Similarity NPD1535 Discovery
0.7181 Intermediate Similarity NPD5401 Approved
0.7179 Intermediate Similarity NPD6234 Discontinued
0.7176 Intermediate Similarity NPD6387 Discontinued
0.7172 Intermediate Similarity NPD5762 Approved
0.7172 Intermediate Similarity NPD5763 Approved
0.7172 Intermediate Similarity NPD7030 Discontinued
0.7164 Intermediate Similarity NPD1778 Approved
0.7164 Intermediate Similarity NPD5238 Clinical (unspecified phase)
0.7164 Intermediate Similarity NPD2556 Approved
0.7164 Intermediate Similarity NPD2554 Approved
0.7163 Intermediate Similarity NPD4062 Phase 3
0.7163 Intermediate Similarity NPD7477 Discontinued
0.7161 Intermediate Similarity NPD4967 Phase 2
0.7161 Intermediate Similarity NPD4965 Approved
0.7161 Intermediate Similarity NPD4966 Approved
0.7154 Intermediate Similarity NPD1398 Phase 1
0.7153 Intermediate Similarity NPD2799 Discontinued
0.7153 Intermediate Similarity NPD4108 Discontinued
0.7153 Intermediate Similarity NPD7258 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7741 Discontinued
0.7143 Intermediate Similarity NPD7054 Approved
0.7143 Intermediate Similarity NPD7046 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7095 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data